Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
28.33
-0.10 (-0.33%)
Dec 20, 2024, 4:00 PM EST - Market closed
Immunocore Holdings Employees
Immunocore Holdings had 497 employees as of December 31, 2023. The number of employees increased by 89 or 21.81% compared to the previous year.
Employees
497
Change (1Y)
89
Growth (1Y)
21.81%
Revenue / Employee
$596,201
Profits / Employee
-$94,660
Market Cap
1.42B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Novavax | 1,543 |
Phreesia | 1,438 |
AtriCure | 1,200 |
Indivior | 1,164 |
Schrödinger | 867 |
InMode | 581 |
Arcus Biosciences | 577 |
Kiniksa Pharmaceuticals International, | 297 |
IMCR News
- 18 days ago - Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma - GlobeNewsWire
- 6 weeks ago - Immunocore to present at upcoming investor conferences - GlobeNewsWire
- 6 weeks ago - Immunocore reports third quarter financial results and provides a business update - GlobeNewsWire
- 3 months ago - Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer - GlobeNewsWire
- 3 months ago - Immunocore to present at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Immunocore: Pipeline Expands HLA Tumor Targeting Beyond Kimmtrak - Seeking Alpha
- 4 months ago - Immunocore Holdings: KIMMTRAK Success, Diverse Pipeline, And Potential Big Pharma Appeal - Seeking Alpha
- 4 months ago - Immunocore Holdings plc (IMCR) Q2 2024 Earnings Call Transcript - Seeking Alpha